Reactive hemophagocytic syndrome in adult-onset still disease: Clinical features, predictive factors, and prognosis in 21 patients

Medicine (United States)

Volumn 94, Issue 4, 2015, Pages

  Bae, Chang Bum ^a   Jung, Ju Yang ^a   Kim, Hyoun Ah ^a   Suh, Chang Hee ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; AZATHIOPRINE; C REACTIVE PROTEIN; CYCLOSPORIN; ETOPOSIDE; FERRITIN; FIBRINOGEN; HEMOGLOBIN; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR INHIBITOR; ANTIINFECTIVE AGENT;

ADULT ONSET STILL DISEASE; ANEMIA; ARTHRALGIA; ARTICLE; BLOOD CELL COUNT; BONE MARROW BIOPSY; CLINICAL ARTICLE; CLINICAL FEATURE; ERYTHROCYTE SEDIMENTATION RATE; ERYTHROPHAGOCYTOSIS; FEMALE; FEVER; HEMOPHAGOCYTIC SYNDROME; HEPATOMEGALY; HUMAN; HUMAN TISSUE; HYPERFERRITINEMIA; HYPERTRIGLYCERIDEMIA; HYPOALBUMINEMIA; HYPOFIBRINOGENEMIA; INFLAMMATION; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOPENIA; LIVER BIOPSY; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; MEDICAL RECORD REVIEW; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RASH; RECURRENCE RISK; SORE THROAT; SPLENOMEGALY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TRIACYLGLYCEROL BLOOD LEVEL; ADULT; AFIBRINOGENEMIA; BLOOD; COMPLICATION; INFECTION; LYMPHATIC DISEASES; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MIDDLE AGED; MORTALITY; RECURRENT DISEASE; RETROSPECTIVE STUDY;

ADULT; AFIBRINOGENEMIA; ANEMIA; ANTI-BACTERIAL AGENTS; FEMALE; FERRITINS; HEPATOMEGALY; HUMANS; HYPERTRIGLYCERIDEMIA; HYPOALBUMINEMIA; INFECTION; L-LACTATE DEHYDROGENASE; LYMPHATIC DISEASES; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; SPLENOMEGALY; STILL'S DISEASE, ADULT-ONSET; THROMBOCYTOPENIA;

EID: 84938062112     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000451     Document Type: Article

References (39)

1. Ramos-Casals M, Brito-Zeron P, Lopez-Guillermo A, et al. Adult haemophagocytic syndrome. Lancet. 2014; 383:1503-1516.
2. Janka GE. Hemophagocytic syndrome. Blood Rev. 2007; 21:235-253.
3. Ravelli A. Macrophage activation syndrome. Curr Opin Rheumatol. 2002; 14:548-552.
4. Larroche G, Mouthon L. Pathogenesis of hemopahgocytic syndrome. Autoimmun Rev. 2004; 3:69-75.
5. Arceci RJ. Whem T cells and macrophage do not talk: the hemophagocytic syndrome. Curr Opin Hematol. 2008; 15:359-367.
6. Canna SW, Behrens EM. Not all hemophagocytes are created equally: appreciating the heterogeneity of the hemophagocytic syndrome. Curr Opin Rheumatol. 2012; 24:113-118.
7. Imashuku S. Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. Int J Hematol. 1997; 66:135-151.
8. Henter JI, Horne A, Arico M., et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007; 48:124-131.
9. Grom AA. Macrophage activation syndrome and reactive hemopha-gocytic lymphohistiocytosis: the same entities? Curr Opin Rheumatol. 2003; 15:587-590.
10. Castillo L, Carcillo J. Secondary hemophagocytic lymphohistiocyto-sis and severe sepsis/systemic inflammatory response syndrome/ multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. Pediatr Crit Care Med. 2009; 10:387-392.
11. Dhote R, Simon J, Papo T., et al. Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum. 2003; 49:633-639.
12. Kumakura S, Ishikura H, Kondo M., et al. Autoimmune-associated hemophagocytic syndrome. Mod Rheumatol. 2004; 14:205-215.
13. Tristano AG. Macrophage activation syndrome: a frequent but under-diagnosed complication associated with rheumatic diseases. Med Sci Monit. 2008; 14:RA27-36.
14. Fukaya S, Yasuda S, Hashimoto T., et al. Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology (Oxford). 2008; 47:1686-1691.
15. Lin CI, Yu HH, Lee J.H., et al. Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases. Clin Rheumatol. 2012; 31:1223-1230.
16. Stephan JL, Kone-Paut I, Gamambrun C., et al. Reactive haemopha-gocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology (Oxford). 2001; 40:1285-1292.
17. Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child. 2001; 85:421-426.
18. Hot A, Toh ML, Cope B, et al. Reactive hemophagocytic syndrome in adult-onset Still disease: clinical feature and long-term outcome: a case-conrol study of 8 patients. Medicine (Baltimore). 2010; 89:37-46.
19. Felix FH, Leal LK, Fontenele JB. Cloak and dagger: the case for adult onset Still disease and hemophagocytic lymphohistiocytosis. Rheumatol Int. 2009; 29:973-974.
20. Arlet JB, Le TH, Marinho A, et al. Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature. Ann Rheum Dis. 2006; 65:1596-1601.
21. Burgi U, Mendez A, Hasler P., et al. Hemophagocytic syndrome in adult-onset Still's disease (AOSD): a must for biologics? Case report and brief review of the literature. Rheumatol Int. 2012; 32:3269-3272.
22. Fujii K, Kitamura Y, Osugi Y., et al. A case of adult-onset Still's disease complicated by hemophagocyti syndrome and interstitial pneumonia with pneumomediastium/recurrent pneumonia. Int J Rheum Dis. 2012; 15:e60-e62.
23. Pamuk ON, Pamuk GE, Usta U, et al. Hemophagocytic syndrome in one patient with adult onset Still's disease: presentation with febrile neutropenia. Clin Rheumatol. 2007; 26:797-800.
24. Kim HS, Park KW, Kim S.K., et al. Two cases of adult onset Still's disease with comcomitant hemophagocytic syndrome. J Rheum Dis. 2007; 14:160-165.
25. Yamaguchi M, Ohta A, Tsunematu T., et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol. 1992; 19:424-430.
26. Pouchot J, Sampalis JS, Beaudet F, et al. Adult Still's disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore). 1991; 70:118-136.
27. Lambotte O, Cacoub P, Costedoat N., et al. High ferritin and low glycosylated ferritin may also be a marker of excessive macrophage activation. J Rheumatol. 2003; 30:1027-1028.
28. Wulffraat NM, Rijkers GT, Elst E, et al. Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation. Rheumatology (Oxford). 2003; 42:375-379.
29. Villanueva J, Lee S, Giannini E.H., et al. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther. 2005; 7:R30-R37.
30. Grom AA. Natural killer cell dysfunction: A common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? Arthritis Rheum. 2004; 50:689-698.
31. Amenomori M, Migita K, Miyashita T., et al. Cytomegalovirus-associated hemophagocytic syndrome in a patient with adult onset Still's disease. Clin Exp Rheumatol. 2005; 23:100-102.
32. Buckley PJ, O'Laughlin S, Komp DM. Histiocytes in familial and infection-induced/idiopathic hemophagocytic syndromes may exhibit phenotypic differences. Pediatr Pathol. 1992; 12:51-66.
33. Mosser DM. The many faces of macrophage activation. J Leukoc Biol. 2003; 73:209-212.
34. Parodi A, Davi S, Pringe A.B., et al. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum. 2009; 60:3388-3399.
35. Gupta A, Weitzman S, Abdelhaleem M. The role of hemophagocy-tosis in bone marrow aspirates in the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2008; 50:192-194.
36. Janka GE, Schneider EM. Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol. 2004; 124: 4-14.
37. Emmenegger U, Frey U, Reimers A., et al. Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes. Am J Hematol. 2001; 68:4-10.
38. Takahashi N, Naniwa T, Banno S. Successful use of etanercept in the treatment of acute lupus hemophagocytic syndrome. Mod Rheumatol. 2008; 18:72-75.
39. Henzan T, Nagafuji K, Tsukamoto H., et al. Success with infl iximab in treating refractory hemophagocytic lymphohistiocytosis. Am J Hematol. 2006; 81:59-61.